Clinical Trial Update: PET/CT for Trop2 ADC Response Evaluation Cancers

View source ↗

Summary

A Trop2-targeted antibody-drug conjugate is being evaluated for breast cancer using PET/CT to measure response, and the study is currently recruiting. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trop2 ADC

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Breast Cancer, Trop2 | Status: RECRUITING